{"id":6370,"date":"2023-06-29T13:55:13","date_gmt":"2023-06-29T11:55:13","guid":{"rendered":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/?p=6370"},"modified":"2023-06-29T13:55:13","modified_gmt":"2023-06-29T11:55:13","slug":"nuevos-permisos","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/nuevos-permisos\/","title":{"rendered":"Nuevos permisos"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"722\" height=\"1024\" src=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2023\/06\/screenshot_20230629-131858-722x1024.png\" alt=\"Screenshot 20230629 131858\" class=\"wp-image-6371\" srcset=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2023\/06\/screenshot_20230629-131858-722x1024.png 722w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2023\/06\/screenshot_20230629-131858-211x300.png 211w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2023\/06\/screenshot_20230629-131858-768x1089.png 768w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2023\/06\/screenshot_20230629-131858.png 1006w\" sizes=\"auto, (max-width: 722px) 100vw, 722px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"714\" height=\"1024\" src=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2023\/06\/screenshot_20230629-131917-714x1024.png\" alt=\"Screenshot 20230629 131917\" class=\"wp-image-6372\" srcset=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2023\/06\/screenshot_20230629-131917-714x1024.png 714w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2023\/06\/screenshot_20230629-131917-209x300.png 209w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2023\/06\/screenshot_20230629-131917-768x1101.png 768w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2023\/06\/screenshot_20230629-131917.png 982w\" sizes=\"auto, (max-width: 714px) 100vw, 714px\" \/><\/figure>\n\n\n\n<p>\ud83d\udc49Ya se han publicado en el BOE los nuevos derechos de conciliaci\u00f3n que se aprobaron en el Consejo de Ministros y Ministras del martes.<\/p>\n\n\n\n<p>\ud83d\udcc6&nbsp;Ma\u00f1ana, 30 de junio, entran en vigor.<\/p>\n\n\n\n<p>Consulta&nbsp;nuestra infograf\u00eda, comp\u00e1rtela y ante cualquier duda consultanos.<\/p>\n\n\n\n<p>CCOO celebra la aprobaci\u00f3n de los nuevos permisos que transponen la directiva europea de conciliaci\u00f3n, pero recordamos que todos ellos han de ser retribuidos para cumplir la normativa y asegurar la corresponsabilidad.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud83d\udc49Ya se han publicado en el BOE los nuevos derechos de conciliaci\u00f3n que se aprobaron en el Consejo de Ministros y Ministras del martes. \ud83d\udcc6&nbsp;Ma\u00f1ana, 30 de junio, entran en &#8230; <a title=\"Nuevos permisos\" class=\"read-more\" href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/nuevos-permisos\/\" aria-label=\"Leer m\u00e1s sobre Nuevos permisos\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":2651,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13,25,26],"tags":[],"class_list":["post-6370","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-towa-pharmaceutical-europe-app-push","category-notesinformatives","category-notesinformatives_ca","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/6370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=6370"}],"version-history":[{"count":1,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/6370\/revisions"}],"predecessor-version":[{"id":6373,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/6370\/revisions\/6373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/2651"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=6370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=6370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=6370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}